AIP
MEDP icon

Arrowpoint Investment Partners’s Medpace MEDP Stock Holding History

Arrowpoint Investment Partners’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-908
Closed -$510K – 117
2025
Q4 		$510K Buy
+908
New +$515K 0.08% 71

Other funds holding MEDP

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Arrowpoint Investment Partners's MEDP Position: Q1 2026 in Review

Arrowpoint Investment Partners sold out of Medpace (MEDP) in Q1 2026, closing a stake of 908 shares — an estimated $510K sold.

Arrowpoint Investment Partners first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $510K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

  • Arrowpoint Investment Partners reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
  • Arrowpoint Investment Partners sold 908 Medpace shares in Q1 2026, an estimated $510K.
  • Arrowpoint Investment Partners first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
  • Arrowpoint Investment Partners's Medpace position peaked at $510K in Q4 2025.
  • 729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Arrowpoint Investment Partners's 13F filing for Q1 2026, filed 14 May 2026.